BIO-TECHNE Corp
TECH· Nasdaq
Filed May 10, 2012 · 10-Q · 40 days after period end · 0001193125-12-223985
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $83.62M | $76.27M | $70.28M |
| Net Income | $31.76M | $31.06M | $32.39M |
| EPS Diluted | $0.86 | $0.84 | $0.87 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 10, 2012 · 40 d after period end